X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10240) 10240
Book Review (1585) 1585
Publication (1013) 1013
Newspaper Article (275) 275
Web Resource (53) 53
Book Chapter (51) 51
Conference Proceeding (43) 43
Book / eBook (42) 42
Magazine Article (40) 40
Government Document (26) 26
Dissertation (19) 19
Streaming Video (11) 11
Trade Publication Article (9) 9
Data Set (3) 3
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8063) 8063
humans (8025) 8025
tuberculosis (5617) 5617
tuberculosis, multidrug-resistant - drug therapy (3557) 3557
male (3176) 3176
infectious diseases (3140) 3140
female (3134) 3134
antitubercular agents - therapeutic use (3133) 3133
mycobacterium tuberculosis - drug effects (2934) 2934
adult (2821) 2821
tuberculosis, multidrug-resistant - epidemiology (2585) 2585
drug resistance (2581) 2581
multidrug-resistant tuberculosis (2395) 2395
middle aged (2125) 2125
tuberculosis, multidrug-resistant - microbiology (1987) 1987
respiratory system (1922) 1922
mycobacterium-tuberculosis (1895) 1895
antitubercular agents - pharmacology (1893) 1893
microbiology (1776) 1776
mycobacterium tuberculosis (1665) 1665
mycobacterium tuberculosis - isolation & purification (1624) 1624
mycobacterium tuberculosis - genetics (1517) 1517
microbial sensitivity tests (1515) 1515
tuberculosis, multidrug-resistant - diagnosis (1471) 1471
pulmonary tuberculosis (1403) 1403
adolescent (1375) 1375
tuberculosis, pulmonary - drug therapy (1314) 1314
aged (1154) 1154
drug resistance in microorganisms (1127) 1127
risk factors (1111) 1111
treatment outcome (1101) 1101
epidemiology (1057) 1057
prevalence (1004) 1004
multidrug-resistant (996) 996
young adult (990) 990
tuberculosis - drug therapy (948) 948
multidrug resistant organisms (934) 934
drug therapy (926) 926
medicine, general & internal (898) 898
child (891) 891
diagnosis (887) 887
immunology (882) 882
retrospective studies (873) 873
pharmacology & pharmacy (841) 841
antitubercular agents (835) 835
research (828) 828
tuberculosis - epidemiology (819) 819
drug resistance, multiple, bacterial (810) 810
rifampin (799) 799
abridged index medicus (789) 789
tuberculosis, pulmonary - epidemiology (782) 782
public health (775) 775
mutation (725) 725
tuberculosis, pulmonary - microbiology (723) 723
hiv (710) 710
tuberculosis, multidrug-resistant - prevention & control (707) 707
antitubercular agents - administration & dosage (696) 696
sputum - microbiology (673) 673
analysis (662) 662
infections (643) 643
patients (643) 643
care and treatment (629) 629
mdr-tb (629) 629
drug-resistance (628) 628
medicine (618) 618
rifampin - pharmacology (604) 604
drug resistance, bacterial (585) 585
incidence (585) 585
genotype (579) 579
research article (577) 577
tuberculosis, pulmonary - diagnosis (559) 559
drug therapy, combination (558) 558
drugs (557) 557
health aspects (555) 555
multidrug resistant tuberculosis (552) 552
tuberculosis, multidrug-resistant (546) 546
child, preschool (528) 528
animals (508) 508
global health (507) 507
isoniazid - pharmacology (504) 504
public, environmental & occupational health (496) 496
mortality (494) 494
aids/hiv (492) 492
rifampin - therapeutic use (488) 488
infection (474) 474
tuberculosis - diagnosis (474) 474
strains (460) 460
tuberculosis - microbiology (457) 457
hiv infections - complications (450) 450
transmission (445) 445
isoniazid (443) 443
isoniazid - therapeutic use (443) 443
human immunodeficiency virus--hiv (439) 439
infectious disease (435) 435
multidisciplinary sciences (430) 430
time factors (427) 427
sensitivity and specificity (422) 422
infant (416) 416
antitubercular agents - adverse effects (414) 414
multidrug resistance (414) 414
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (40) 40
Gerstein Science - Stacks (23) 23
West Park Healthcare Centre - Stacks (8) 8
Robarts - Government Pubs (3) 3
Scarborough Hospital - Online (3) 3
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Media Commons - Microtexts (1) 1
St. Michael's Hospital - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9523) 9523
Spanish (230) 230
French (185) 185
Russian (172) 172
Japanese (134) 134
Chinese (118) 118
German (95) 95
Portuguese (81) 81
Korean (48) 48
Italian (30) 30
Turkish (24) 24
Romanian (23) 23
Polish (22) 22
Czech (14) 14
Dutch (14) 14
Swedish (14) 14
Ukrainian (12) 12
Danish (9) 9
Norwegian (7) 7
Hungarian (6) 6
Bosnian (4) 4
Finnish (4) 4
Lithuanian (4) 4
Serbian (4) 4
Croatian (3) 3
Slovak (2) 2
Arabic (1) 1
Icelandic (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


LANCET, ISSN 0140-6736, 07/2011, Volume 378, Issue 9785, pp. 57 - 72
Tuberculosis results in an estimated 1.7 million deaths each year and the worldwide number of new cases (more than 9 million) is higher than at any other time... 
MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, GENERAL & INTERNAL | RESOURCE-LIMITED SETTINGS | RECONSTITUTION INFLAMMATORY SYNDROME | SUB-SAHARAN AFRICA | MULTIDRUG-RESISTANT TUBERCULOSIS | HIV-ASSOCIATED TUBERCULOSIS | ACID AMPLIFICATION TESTS | PULMONARY TUBERCULOSIS | ANTIRETROVIRAL THERAPY | HUMAN-IMMUNODEFICIENCY-VIRUS
Journal Article
by Furin, J and Cox, H and Pai, M
LANCET, ISSN 0140-6736, 04/2019, Volume 393, Issue 10181, pp. 1642 - 1656
Tuberculosis remains the leading cause of death from an infectious disease among adults worldwide, with more than 10 million people becoming newly sick from... 
MYCOBACTERIUM-TUBERCULOSIS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | MULTIDRUG-RESISTANT | COST-EFFECTIVENESS | LATENT TUBERCULOSIS | PULMONARY TUBERCULOSIS | MDR-TB | XDR-TB | XPERT MTB/RIF | DRUG-RESISTANT TUBERCULOSIS
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 01/2017, Volume 187, Issue 1, pp. 160 - 173
Journal Article
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, ISSN 0012-0472, 10/2015, Volume 140, Issue 20, pp. 1508 - 1512
Zusammenfassung Die Tuberkulose gehort zu den bedeutendsten Ursachen fur Morbiditat und Mortalitat weltweit. Die zunehmende Entwicklung multiresistenter Stamme... 
personliche Medizin | ASSAY | Gesamt-Genomsequenzierung | whole-genome sequencing | MDR-TB | update | REGIMEN | XPERT MTB/RIF | RIFAPENTINE | IGRA | personalized medicine | EUROPE | MEDICINE, GENERAL & INTERNAL | MULTIDRUG-RESISTANT TUBERCULOSIS | MOXIFLOXACIN | RISK-ASSESSMENT
Journal Article
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 09/2014, Volume 18, Issue 9, pp. 1019 - 1025
BACKGROUND: Effective treatment for drug-susceptible tuberculosis (TB) rapidly renders patients noninfectious, long before conversion of sputum acid-fast smear... 
Impact of treatment | Multidrug-resistant tuberculosis | Extensively drug-resistant tuberculosis | Transmission | MYCOBACTERIUM-TUBERCULOSIS | TUBERCLE-BACILLI | SOUTH-AFRICA | INFECTIOUS DISEASES | multidrug-resistant tuberculosis | SETTINGS | CHEMOTHERAPY | VARIABILITY | transmission | impact of treatment | WARD | RESPIRATORY SYSTEM | extensively drug-resistant tuberculosis | PULMONARY TUBERCULOSIS | INFECTION | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Air Microbiology | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Infection Control - methods | Mycobacterium tuberculosis - drug effects | Tuberculin Test | Tuberculosis, Multidrug-Resistant - diagnosis | Cross Infection - transmission | Microbial Sensitivity Tests | Young Adult | Time Factors | Tuberculosis, Multidrug-Resistant - microbiology | Tuberculosis, Multidrug-Resistant - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Retrospective Studies | Antitubercular Agents - therapeutic use | Extensively Drug-Resistant Tuberculosis - drug therapy | Guinea Pigs | Cross Infection - prevention & control | Treatment Outcome | Mycobacterium tuberculosis - isolation & purification | Animals | Extensively Drug-Resistant Tuberculosis - transmission | Tuberculosis, Pulmonary - diagnosis | Cross Infection - microbiology | Adolescent | Cross Infection - diagnosis | Aged | Tuberculosis, Pulmonary - transmission | Tuberculosis, Multidrug-Resistant - drug therapy | Index Medicus | multidrug resistant tuberculosis | extensively drug resistant tuberculosis
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 1/2013, Volume 207, Issue 1, pp. 9 - 17
Background. Extensively drug-resistant tuberculosis (XDR-tuberculosis) is a global public health threat, but few data exist elucidating factors driving this... 
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | tuberculosis | genotyping | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | CARE | transmission | NEW-YORK-CITY | INFECTED PATIENTS | drug resistance | XDR-TB | OUTBREAK | SPREAD | STRAIN | EPIDEMIOLOGY | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2015, Volume 61, Issue suppl 3, pp. S102 - S118
Despite concerted efforts over the past 2 decades at developing new diagnostics, drugs, and vaccines with expanding pipelines, tuberculosis remains a global... 
diagnostics | Tuberculosis | drugs | management | vaccines | MYCOBACTERIUM-TUBERCULOSIS | INFECTIOUS DISEASES | INTENSIVE PHASE TREATMENT | SUB-SAHARAN AFRICA | tuberculosis | AFRICAN POUCHED RATS | MICROBIOLOGY | IMMUNOLOGY | CROSS-PRIMING AMPLIFICATION | IN-VITRO | BACTERICIDAL ACTIVITY | MULTIDRUG-RESISTANT TUBERCULOSIS | PULMONARY TUBERCULOSIS | STANDARDIZED TREATMENT | Extensively Drug-Resistant Tuberculosis - drug therapy | Antitubercular Agents - chemistry | Point-of-Care Systems - economics | World Health Organization | Tuberculosis Vaccines | Extensively Drug-Resistant Tuberculosis - prevention & control | Humans | Tuberculosis - complications | Clinical Trials as Topic | Mycobacterium tuberculosis - drug effects | Tuberculosis - diagnosis | Tuberculosis, Multidrug-Resistant - diagnosis | Antitubercular Agents - classification | Tuberculosis, Multidrug-Resistant - prevention & control | Tuberculosis - drug therapy | Tuberculosis - prevention & control | HIV Infections - complications | Extensively Drug-Resistant Tuberculosis - diagnosis | Antitubercular Agents - therapeutic use | Mycobacterium tuberculosis - genetics | Tuberculosis, Multidrug-Resistant - drug therapy | Infectious diseases | Medical diagnosis | Drug therapy | Drug resistance | Index Medicus | A Blueprint for Opportunities | Advances in Tuberculosis Research
Journal Article
Journal Article
JNP-JOURNAL FOR NURSE PRACTITIONERS, ISSN 1555-4155, 01/2015, Volume 11, Issue 1, pp. 87 - 94
Tuberculosis (TB) resulted in 1.3 million deaths and 8.6 million new cases of active TB worldwide in 2012. Clinical manifestations of TB include fever, night... 
acid-fast bacilli | latent TB | MULTIDRUG-RESISTANT | isoniazid | NURSING | pyrazinamide | tuberculosis | multidrug-resistant TB | tuberculin skin test | DRUG-RESISTANT TUBERCULOSIS | rifampin | ethambutol | interferon-gamma-release assay | INFECTION
Journal Article
Lancet (London, England), 03/2016, Volume 387, Issue 10024, p. 1211
Journal Article
Journal for Nurse Practitioners, ISSN 1555-4155, 2015, Volume 11, Issue 1, pp. 87 - 94
Tuberculosis (TB) resulted in 1.3 million deaths and 8.6 million new cases of active TB worldwide in 2012. Clinical manifestations of TB include fever, night... 
Latent TB | Multidrug-resistant TB | Tuberculosis | Acid-fast bacilli | Tuberculin skin test | Interferon-γ-release assay | Ethambutol | Pyrazinamide | Isoniazid | Rifampin
Journal Article
The Journal for Nurse Practitioners, ISSN 1555-4155, 01/2015, Volume 11, Issue 1, pp. 87 - 94
Tuberculosis (TB) resulted in 1.3 million deaths and 8.6 million new cases of active TB worldwide in 2012. Clinical manifestations of TB include fever, night... 
acid-fast bacilli | latent TB | isoniazid | rifampin | ethambutol | pyrazinamide | tuberculosis | multidrug-resistant TB | interferon-γ-release assay | tuberculin skin test
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, pp. e92077 - e92077
Background: This study aims to evaluate the outcomes of adults hospitalized for tuberculosis in a higher-income region with low HIV prevalence. Methods: A... 
DIAGNOSIS | IMPACT | TRANSMISSION | RISK-FACTORS | CITY | PREDICTORS | MULTIDISCIPLINARY SCIENCES | PULMONARY TUBERCULOSIS | INPATIENTS | DEATH | DELAY | Tuberculosis, Pulmonary - microbiology | Coinfection | Humans | Middle Aged | Tuberculosis, Lymph Node - drug therapy | Male | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Lymph Node - mortality | Tuberculosis, Multidrug-Resistant - diagnosis | Tuberculosis, Pleural - drug therapy | Tuberculosis, Multidrug-Resistant - microbiology | HIV Infections - diagnosis | Female | HIV Infections - mortality | Retrospective Studies | Tuberculosis, Urogenital - microbiology | Tuberculosis, Lymph Node - microbiology | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - mortality | Hospital Mortality | HIV Infections - virology | Tuberculosis, Pleural - mortality | Tuberculosis, Urogenital - mortality | Fluoroquinolones - therapeutic use | Delayed Diagnosis | Mycobacterium tuberculosis - isolation & purification | Tuberculosis, Central Nervous System - microbiology | Tuberculosis, Lymph Node - diagnosis | HIV | Tuberculosis, Pulmonary - mortality | Tuberculosis, Pulmonary - diagnosis | Tuberculosis, Urogenital - drug therapy | Tuberculosis, Central Nervous System - drug therapy | Survival Analysis | Tuberculosis, Urogenital - diagnosis | HIV Infections - drug therapy | Aged | Tuberculosis, Central Nervous System - mortality | Tuberculosis, Pleural - microbiology | Tuberculosis, Pleural - diagnosis | Tuberculosis, Central Nervous System - diagnosis | Tuberculosis, Multidrug-Resistant - drug therapy | Medical research | Hospital patients | Tuberculosis | Analysis | Mortality | Medicine, Experimental | Respiratory tract diseases | Adults | Research | HIV (Viruses) | Fluoroquinolones | Lung | Lung diseases | Systematic review | Infections | Histology | Malignancy | Drug resistance | Medical diagnosis | Patients | Medicine | Infectious diseases | Hospitals | Hypoxemia | Acquired immune deficiency syndrome--AIDS | Microscopy | Human immunodeficiency virus--HIV | Smear | Population | Diagnosis | Culture | Index Medicus | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.